Abstracts From the Literature

Drug: Remicade Article: The Safety Profile of Infliximab in Patients with Crohn's Disease: The Mayo Clinic Experience in 500 Patients Journal: Gastroenterology, 2003 Jan; 126(1): 19-31 Authors: J.F. Colombel, E.V. Loftus, Jr., W.J. Tremaine, L.J. Egan, W.S. Harmsen, C.D. Schleck, A.R. Zinsmeister, W.J. Sandborn

Summary: The article describes a study designed to evaluate the short- and long-term safety of infliximab (Remicade, Centocor) in patients with Crohn's disease by examining the medical records of 500 patients treated with the drug at the Mayo Clinic. The patients' medical records were reviewed and abstracted for demographic features and adverse events. The 500 patients …